https://orcid.org/0000-0003-1532-6049
References
- Cereda A, Carey JC. The trisomy 18 syndrome. Orphanet J Rare Dis. 2012;7:81.
- Batees H, Altirkawi KA. Trisomy 18 syndrome: towards a balanced approach. Sudan J Paediatr. 2014;14(2):76–84.
- Baer RJ, Flessel MC, Jelliffe-Pawlowski LL, et al. Detection rates for aneuploidy by first-trimester and sequential screening. Obstet Gynecol. 2015;126(4):753–759.
- Kroes I, Janssens S, Defoort P. Ultrasound features in trisomy 13 (Patau syndrome) and trisomy 18 (Edwards syndrome) in a consecutive series of 47 cases. Facts Views Vis Obgyn. 2014;6(4):245–249.
- Naor DM, Maymon R, Keidar R, et al. Prenatal diagnosis of trisomy 13 and trisomy 18: the experience of Assaf-Harofe Medical Center. Harefuah. 2014;153(8):453–457.
- Taketa K, Ichikawa E, Sakuda H, et al. Lectin reactivity of alpha-fetoprotein in a case of renal cell carcinoma. Tumour Biol. 1989;10(5):275–280.
- Qi F, Zhou A, Yan L, et al. The diagnostic value of PIVKA-II, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma. J Clin Lab Anal. 2020;34(5):e23158.
- Choi J, Kim GA, Han S, et al. Longitudinal assessment of three serum biomarkers to detect very early-stage hepatocellular carcinoma. Hepatology. 2019;69(5):1983–1994.
- Yamamoto R, Azuma M, Wakui Y, et al. Alpha-fetoprotein microheterogeneity: a potential biochemical marker for Down's syndrome. Clin Chim Acta. 2001;304(1–2):137–141.
- Yamamoto R, Minobe S, Ebina Y, et al. Prenatal Trisomy 21 screening using the lens culinaris agglutinin-reactive alpha-fetoprotein ratio. Congenit Anom (Kyoto). 2004;44(2):87–92.
- Yu J, He LM, Hu HY, et al. The application of alpha-fetoprotein isoform L2 test in screening Down's syndrome. Int J Lab Med. 2015;36(18):2643–2644.
- Wu H, Zhang YS, Wu XX, et al. The value of variants of alpha-fetoprotein (AFP) for Down's syndrome screening. Chin J Birth Health Hered. 2012;20(2):56–57.
- China Maternal and Child Health Monitoring Workbook. Chinese Maternal and child health monitoring and newsletter. Vol. 50. Beijing: Department of Maternal and Child Health and Community Health; 2013. p. 222–223.
- Guidelines for the reporting of difficult and minor malformations in birth defects monitoring systems in China (Trial version 2012). Chinese Maternal and child health monitoring and newsletter. Vol. 50. Beijing: Department of Maternal and Child Health and Community Health; 2013. p. 1–7.
- Royston P, Thompson SG. Model-based screening by risk with application to Down's syndrome. Stat Med. 1992;11(2):257–268.
- Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol. 1987;94(5):387–402.
- Chen Y, Huang J, Mei J. A risk prediction model for fetal hypospadias by testing maternal serum AFP and free beta-HCG. Clin Biochem. 2019;69(7):21–25.
- Huai L, Leng J, Ma S, et al. Replacing alpha-fetoprotein with alpha-fetoprotein-L3 increases the sensitivity of prenatal screening for Trisomy 21. Am J Ther. 2016;23(6):e1754–e1757.
- Chen YM, Lu S, Lian JJ, et al. Clinical value of maternal serum Alpha-fetoprotein heterostructure L2 and L3 in screening for Down's syndrome in second trimester. Zhejiang Med J. 2019;41(1):27–30.
- Chunfang G, Meng F, Jun J. Expert consensus on clinical application of multidisciplinary alpha-fetoprotein heterosomes. Lab Med. 2017;32(5):347–452.
- Egashira Y, Suganuma M, Kataoka Y, et al. Establishment and characterization of a fucosylated alpha-fetoprotein-specific monoclonal antibody: a potential application for clinical research. Sci Rep. 2019;9(1):12359.
- Yamao T, Yamashita YI, Imai K, et al. Clinical significance of preoperative hepatocellular carcinoma with high lens culinaris agglutinin-reactive fraction of alpha-fetoprotein, but low alpha-fetoprotein. Anticancer Res. 2019;39(2):883–889.
- Li J, Gao T, Gu S, et al. An electrochemical biosensor for the assay of alpha-fetoprotein-L3 with practical applications. Biosens Bioelectron. 2017;87:352–357.